2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on IO in Metastatic Melanoma: Is the Addition of Ipilimumab to anti- PD-1 Beneficial in Patients Resistant to PD-1 Monotherapy?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Adil Daud
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Adil Daud
Login to view comments.
Click here to Login
